Mode
Text Size
Log in / Sign up
N/A N=118 Randomized Treatment

Illness Management and Recovery for Veterans With Severe Mental Illness

Schizophrenia · Schizo-affective Disorder

Enrolled (actual)
118
Serious AEs
0.0%
Results posted
Oct 2014
Primary outcome: Primary: Illness Management Ratings — 3.5; 3.3; 3.5; 3.6 units on a scale — p=.8868

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Illness Management and Recovery (Behavioral); Problem Solving (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Apr 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Illness Management Ratings
3.5; 3.3; 3.5; 3.6; 3.6; 3.5 .8868
SECONDARY
Psychiatric Symptoms (PANSS Total)
75.1; 76.1; 68.5; 66.6; 61.9; 65.3 .3328

Summary

The President's New Freedom Commission on Mental Health has called for a transformation of the mental health system to partner with consumers of those services in delivering effective interventions focused on recovery, and the Department of Veterans Affairs (VA) has developed a Mental Health Strategic Plan to address these recommendations. One promising approach is to implement Illness Management and Recovery (IMR), a structured curriculum to help mental health consumers manage their illnesses and pursue goals related to recovery from mental illness. IMR was developed from a review of effective approaches for illness self-management training in persons with severe mental illness. The 9-month curriculum is taught using motivational, educational, and cognitive-behavioral techniques, and incorporates five evidence-based practices: education about mental illness, strategies for increasing medication adherence, skills training to enhance social support, relapse prevention planning, and coping skills training. The program was developed for widespread dissemination and includes a manual, worksheets, an introductory video, a clinical training video, a fidelity scale, and informational brochures for consumers, family members, clinicians, and administrators.

Eligibility Criteria

Inclusion Criteria

  • Currently receiving (or newly admitted to) mental health services from any mental health treatment programs at the Roudebush VAMC or Midtown Community Mental Health Center (MCMHC) in Indianapolis, IN
  • Age 18 or older
  • SCID-confirmed diagnosis of schizophrenia or schizoaffective disorder
  • Stated interest in learning more about their illness
  • Willing and able to give informed consent

Exclusion Criteria

  • Severe medical condition that would limit participation in an 18-month study (e.g., end stage renal disease, metastatic cancer, life expectancy less than 18 months; if participant is unsure, with permission will contact primary physician)
  • Evidence of dementia or severe cognitive dysfunction on cognitive screener
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00515671). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search